Technical and efficiency growth rates of biopharmaceutical firms in China Online publication date: Tue, 20-Nov-2007
by Yao-Chun Lee, Yu-Hsueh Hsu, Jaw-Ming Chen
International Journal of Biotechnology (IJBT), Vol. 9, No. 6, 2007
Abstract: This paper presents a study of 37 biopharmaceutical firms in China during 2002–2004. Malmquist-DEA and linear regression for panel data were used to analyse the effect of Technical Growth Rate (TGR) and Efficiency Growth Rate (EGR) on Sales Volumes Growth Rate (SGR). Sales volume is the single output. Fixed assets, non-technical staff number and technical staff number are the three inputs. All nominal terms are transformed into real terms in 2002 prices by GDP deflators. Our major findings are as follows: (1) Average Efficiency Growth Rate (AEGR) and Average Real Sales Volumes Growth Rate (ASGR) of small and medium firms have similar trends. (2) AEGR, Average Technical Growth Rate (ATGR) and ASGR are different trends for large firms. (3) The EGR and TGR significantly affect the SGR of biopharmaceutical firms. (4) The ATGR of large firms is greater than that of small and medium firms. (5) The AEGR of small and medium firms is greater than that of large firms.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook